MCHX

Rating neutralAI Memo

Marchex

As of 2026-09-09/Confidence medium/Horizon 6‑12m

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-09-09 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

neutral

Confidence

medium

Horizon

6‑12m

Key catalyst

Q3 2026 execution against company outlook • 2026-12-08

Base target: $2 / p=50% prob

Biggest risk

The thesis depends on integrating Archenia and converting pilots across a concentrated customer base. Q2 reported revenue was down year over year, the company remained loss-making on a GAAP basis, and execution or margin slippage could pressure the shares.

Invalidation

Break below $1 or thesis failure.

What would change my mind?

The Archenia combination could expand Marchex's addressable customer-acquisition spend, improve deal sizes, and support the guided Q3 revenue and EBITDA step-up if early pilots become recurring deployments.

Research note

Recommendation

neutral

Confidence

medium

As of

2026-09-09

Base target

p=50%

Bull target

p=25%

Bear target

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Pilot-conversion or guidance execution shortfall
Archenia integration and customer cross-selling
The Archenia combination could expand Marchex's addressable customer-acquisition spend, improve deal sizes, and support the guided Q3 revenue and EBITDA step-up if early pilots become recurring deployments.

BearKey bullets

Archenia integration and cross-selling may not translate into recurring revenue.
Customer concentration is high, with the top 100 customers representing approximately 90% of revenue.
Q2 GAAP results remained loss-making and included acquisition and reorganization costs.

WatchKey bullets

Q3 2026 execution against company outlook

Summary

High-level snapshot

Recommendation

neutral

Model confidence

medium

Timeframe

6‑12m

Asset

Equity

Trigger

Base case: $2 (p=50%)

Target spread vs base: +50% / -50%

Scenario probabilities

Bull Target: $3 (p=25%)Base Target: $2 (p=50%)Bear Target: $1 (p=25%)

Commentary

Tone is cautiously constructive after the Archenia acquisition and Q3 outlook, but the evidence base is thin. The packet does not establish a reliable post-release price reaction, analyst estimate revisions, options positioning, short interest, or social coverage; missing reaction data is not positive evidence.

As of 2026-09-09 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Pilot-conversion or guidance execution shortfall
Archenia integration and customer cross-selling

Scenarios

Bull Target (Scenario probability)

$3 / p=25% prob

Base Target (Scenario probability)

$2 / p=50% prob

Bear Target (Scenario probability)

$1 / p=25% prob

Analysis 2026-09-09 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

0.00

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-12-08
Q3 2026 execution against company outlook
Management guided to Q3 revenue of $16.0-$16.5 million and adjusted EBITDA of $2.3-$2.5 million, reflecting a full quarter of Archenia contribution. The next report should test integration, organic growth, and margin delivery [#SEC-8K-2026-08-12].
Prob 70.00% • Move 20.00% • Priced-in 35.00%

Short-term Catalysts

Next few weeks

Pilot-conversion or guidance execution shortfall
2026-12-08
Downside is material if Marchex fails to convert paid pilots into recurring deployments, misses the Q3 outlook, or cannot sustain profitability after acquisition-related costs. Q2 reported revenue declined year over year despite improved adjusted EBITDA before one-time costs [#SEC-8K-2026-08-12].
Prob 40% • Move -35% • Priced-in 20%

Long-term Catalysts

Months to a year

Archenia integration and customer cross-selling
2027-09-09
The acquisition expands Marchex from conversational analytics toward automated customer acquisition and measurable outcomes. Early adoption and paid pilots are encouraging, but broader recurring conversion remains unproven [#SEC-8K-2026-08-12] [#PR-EARNINGS-2026-08-13].
Prob 55% • Move 55% • Priced-in 25%

Risks

Archenia integration and cross-selling may not translate into recurring revenue.
Customer concentration is high, with the top 100 customers representing approximately 90% of revenue.
Q2 GAAP results remained loss-making and included acquisition and reorganization costs.
Q3 guidance may prove difficult to achieve after the full-quarter acquisition contribution is included.
The peer set is loose and analyst coverage is insufficient for a robust consensus valuation.

Peers

Symbol	Summary
GIBO	Same-sector, similar-market-cap screen candidate; operating overlap with Marchex is not established, so valuation comparison is weak.
GRSD	Same-sector, similar-market-cap screen candidate; no evidence packet support for direct product or customer overlap.
PODC	Media and entertainment peer by sector and size, but business-model overlap with AI-driven conversation analytics is limited and unverified.
SCOR	Data-driven media/measurement peer with some thematic adjacency, but direct operating comparability is not established.
SEAT	Same-sector, similar-market-cap candidate; customer and monetization overlap with Marchex is not supported by the packet.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-09-09

Loading AI feed…

Symbol

Summary

GIBO

Same-sector, similar-market-cap screen candidate; operating overlap with Marchex is not established, so valuation comparison is weak.

GRSD

Same-sector, similar-market-cap screen candidate; no evidence packet support for direct product or customer overlap.

PODC

Media and entertainment peer by sector and size, but business-model overlap with AI-driven conversation analytics is limited and unverified.

SCOR

Data-driven media/measurement peer with some thematic adjacency, but direct operating comparability is not established.

SEAT

Same-sector, similar-market-cap candidate; customer and monetization overlap with Marchex is not supported by the packet.